Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04OQU
|
|||
| Former ID |
DNCL001647
|
|||
| Drug Name |
ASP2408
|
|||
| Synonyms |
CTLA4-Ig fusion protein
Click to Show/Hide
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 1 | [1] | |
| Company |
Astellas Pharma US; Perseid Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02052375) A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With RheumatoidArthritis on Methotrexate. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.